Joanna Grech, A. Gemmell, J. Patrick, Rufus Turner, K. Graham
{"title":"2020年4月至2021年3月,苏格兰西部地区COVID-19对诊断时局部晚期宫颈癌分期的影响","authors":"Joanna Grech, A. Gemmell, J. Patrick, Rufus Turner, K. Graham","doi":"10.1136/ijgc-2022-ESGO.104","DOIUrl":null,"url":null,"abstract":"2022-RA-1242-ESGO Table 1ConclusionThere was no significant difference in median primary tumour size, but more patients had lymph node involvement and stage IVA disease in 2020 – 2021, suggesting a delay to presentation and/or diagnosis. Inclusion of patients with more advanced disease who were directed to systemic anti-cancer therapy or best supportive care would provide a more comprehensive analysis of the effect of the pandemic on cervical cancer stage at diagnosis.","PeriodicalId":114847,"journal":{"name":"Cervical cancer","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2022-RA-1242-ESGO Impact of COVID-19 on stage of locally advanced cervical cancer at diagnosis in the West of Scotland, April 2020 – March 2021\",\"authors\":\"Joanna Grech, A. Gemmell, J. Patrick, Rufus Turner, K. Graham\",\"doi\":\"10.1136/ijgc-2022-ESGO.104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"2022-RA-1242-ESGO Table 1ConclusionThere was no significant difference in median primary tumour size, but more patients had lymph node involvement and stage IVA disease in 2020 – 2021, suggesting a delay to presentation and/or diagnosis. Inclusion of patients with more advanced disease who were directed to systemic anti-cancer therapy or best supportive care would provide a more comprehensive analysis of the effect of the pandemic on cervical cancer stage at diagnosis.\",\"PeriodicalId\":114847,\"journal\":{\"name\":\"Cervical cancer\",\"volume\":\"13 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cervical cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2022-ESGO.104\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cervical cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-ESGO.104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
2022-RA-1242-ESGO Impact of COVID-19 on stage of locally advanced cervical cancer at diagnosis in the West of Scotland, April 2020 – March 2021
2022-RA-1242-ESGO Table 1ConclusionThere was no significant difference in median primary tumour size, but more patients had lymph node involvement and stage IVA disease in 2020 – 2021, suggesting a delay to presentation and/or diagnosis. Inclusion of patients with more advanced disease who were directed to systemic anti-cancer therapy or best supportive care would provide a more comprehensive analysis of the effect of the pandemic on cervical cancer stage at diagnosis.